Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans.

Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE.

Prostate. 2008 Mar 1;68(4):354-9. doi: 10.1002/pros.20687.

PMID:
18189233
[PubMed - indexed for MEDLINE]
2.

Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.

Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ.

Clin Cancer Res. 2007 Oct 1;13(19):5959-64.

PMID:
17908993
[PubMed - indexed for MEDLINE]
Free Article
3.

Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, Thompson IM, Leach RJ.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):588-99. doi: 10.1158/1055-9965.EPI-09-0864. Epub 2010 Jan 19.

PMID:
20086112
[PubMed - indexed for MEDLINE]
Free Article
4.

Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.

Okobia MN, Zmuda JM, Ferrell RE, Patrick AL, Bunker CH.

Prostate. 2011 Jul;71(10):1054-63. doi: 10.1002/pros.21320. Epub 2011 Jan 12.

PMID:
21557270
[PubMed - indexed for MEDLINE]
5.

ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago.

Shea PR, Ferrell RE, Patrick AL, Kuller LH, Bunker CH.

Hum Genet. 2002 Oct;111(4-5):398-400. Epub 2002 Aug 21.

PMID:
12384782
[PubMed - indexed for MEDLINE]
6.

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):949-57.

PMID:
15824169
[PubMed - indexed for MEDLINE]
Free Article
7.

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer.

Wiklund F, Jonsson BA, Brookes AJ, Strömqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Bälter K, Grönberg H.

Clin Cancer Res. 2004 Nov 1;10(21):7150-6.

PMID:
15534086
[PubMed - indexed for MEDLINE]
Free Article
8.

Prostate cancer risk is three-fold higher among men, aged 50-64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago.

Bunker CH, Patrick AL, Maharaj G, Keenan HA, Ramnarine S, Belle A, Richard JR, Dhir R.

Ethn Dis. 2002 Fall;12(4):S3-30-3.

PMID:
12477151
[PubMed - indexed for MEDLINE]
9.

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.

Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA.

Prostate. 2008 Dec 1;68(16):1790-7. doi: 10.1002/pros.20841.

PMID:
18767027
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

PMID:
17035411
[PubMed - indexed for MEDLINE]
Free Article
11.

RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis.

Li H, Tai BC.

Clin Cancer Res. 2006 Oct 1;12(19):5713-9.

PMID:
17020975
[PubMed - indexed for MEDLINE]
Free Article
12.

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS.

Nat Genet. 2002 Dec;32(4):581-3. Epub 2002 Nov 4.

PMID:
12415269
[PubMed - indexed for MEDLINE]
13.

Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.

Fesinmeyer MD, Kwon EM, Fu R, Ostrander EA, Stanford JL.

Prostate. 2011 Oct 1;71(14):1538-47. doi: 10.1002/pros.21370. Epub 2011 Feb 25.

PMID:
21360564
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.

Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1203-13. doi: 10.1158/1055-9965.EPI-07-2811.

PMID:
18483343
[PubMed - indexed for MEDLINE]
Free Article
15.

Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection.

Summers K, Crespi B.

Infect Genet Evol. 2008 May;8(3):297-301. doi: 10.1016/j.meegid.2008.01.004. Epub 2008 Jan 18.

PMID:
18295551
[PubMed - indexed for MEDLINE]
16.

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.

Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S, Yamanaka H.

Br J Cancer. 2003 Aug 18;89(4):691-6.

PMID:
12915880
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic variation in RNASEL associated with prostate cancer risk and progression.

Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA.

Carcinogenesis. 2010 Sep;31(9):1597-603. doi: 10.1093/carcin/bgq132. Epub 2010 Jun 24.

PMID:
20576793
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.

Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, Bailey-Wilson JE, Burk RD.

Prostate. 2010 Nov 1;70(15):1716-27. doi: 10.1002/pros.21207.

PMID:
20564318
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.

Miljkovic-Gacic I, Bunker CH, Ferrell RE, Kammerer CM, Evans RW, Patrick AL, Kuller LH.

Metabolism. 2006 Jan;55(1):96-102.

PMID:
16324926
[PubMed - indexed for MEDLINE]
20.

RNASEL -1385G/A polymorphism and cancer risk: a meta-analysis based on 21 case-control studies.

Zhang LF, Mi YY, Qin C, Wang Y, Cao Q, Wei JF, Zhou YJ, Feng NH, Zhang W.

Mol Biol Rep. 2011 Nov;38(8):5099-105. doi: 10.1007/s11033-010-0657-2. Epub 2011 Jan 9.

PMID:
21221811
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk